Gliclazide, a K<sub>ATP</sub> channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway.
| Author | |
|---|---|
| Year of Publication | :
2018
|
| Journal | :
Vascular pharmacology
|
| Date Published | :
2018
|
| ISSN Number | :
1537-1891
|
| DOI | :
10.1016/j.vph.2018.01.001
|
| Short Title | :
Vascul Pharmacol
|
| Download citation |